Wed, Apr 16, 2014, 12:22 AM EDT - U.S. Markets open in 9 hrs 8 mins

Recent

% | $
Quotes you view appear here for quick access.

Alexza Pharmaceuticals Inc. Message Board

  • elfsysop elfsysop May 10, 2013 11:04 AM Flag

    Stock will tread water until next catalyst

     

    1. Post marketing clinical trial results will be the boom/bust IMO as the design (by TEVA) will no doubt address every question concerned FDA panel members had.

    2. Quarterly earnings reports will show how effective TEVA and Grupo Ferrer are at injecting Adisave into the market, as well as how Alexza management is handling its new money.

    3. Guidance reports will tell us how the market is receiving the Adusave and what to expect going forward as well as how much research spending to expect, future NDA catalysts for new products, etc.

    Until these next catalysts, barring unforeseen disasters (harm to patients, deaths, manufacturing failures, quality issues) everything else is market manipulation or rumor mongering. This innovative drug delivery system has a long future and promises great returns to the patient disciplined stock holder, IMHO.

    To the traders looking to make fast money, this is not your father's biotech company - no big moves up or down are going to be seen here (IMHO of course).

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ALXA
4.17+0.10(+2.46%)Apr 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.